| Literature DB >> 32089431 |
Charles E Rupprecht1, Bernadette Abela-Ridder2, Ronello Abila3, Anna Charinna Amparo4, Ashley Banyard5, Jesse Blanton6, Karoon Chanachai7, Kai Dallmeier8, Katinka de Balogh9, Victor Del Rio Vilas10, Hildegund Ertl11, Conrad Freuling12, Richard Hill13, Guy Houillon14, Miia Jakava-Viljanen15, Suwicha Kasemsuwan16, Jacques Léchenet17, Louis Nel18, Pranee Panichabhongse7, Sira Abdul Rahman19, Terapong Tantawichien20, Joris Vandeputte21, Wittawat Viriyabancha22, Ad Vos23, Ryan Wallace24, Gowri Yale25, Onphirul Yurachai26, Thomas Mueller12.
Abstract
Rabies is a major neglected zoonotic disease and causes a substantial burden in the Asian region. Currently, Pacific Oceania is free of rabies but enzootic areas throughout southeast Asia represent a major risk of disease introduction to this region. On September 25-26, 2019, researchers, government officials and related stakeholders met at an IABS conference in Bangkok, Thailand to engage on the topic of human rabies mediated by dogs. The objective of the meeting was focused upon snowballing efforts towards achieving substantial progress in rabies prevention, control and elimination within Asia by 2030, and thereby to safeguard the Pacific region. Individual sessions focused upon domestic animal, wildlife and human vaccination; the production and evaluation of quality, safety and efficacy of existing rabies biologics; and the future development of new products. Participants reviewed the progress to date in eliminating canine rabies by mass vaccination, described supportive methods to parenteral administration by oral vaccine application, considered updated global and local approaches at human prophylaxis and discussed the considerable challenges ahead. Such opportunities provide continuous engagement on disease management among professionals at a trans-disciplinary level and promote new applied research collaborations in a modern One Health context.Entities:
Keywords: Dog; Lyssavirus; Prophylaxis; Rabies; Vaccine; Zoonosis
Mesh:
Substances:
Year: 2020 PMID: 32089431 DOI: 10.1016/j.biologicals.2020.01.008
Source DB: PubMed Journal: Biologicals ISSN: 1045-1056 Impact factor: 1.856